Diethylamine

Diethylamine

SCHEMBL7124948

C#CC(O)(c1ccccc1)c1ccccc1.CCNCC

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 2/20 0.37
PABPC1 P11940 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
CYP2C19 P33261 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL7269785 0.86 ALDH1A1 (0.45) KCNN4ALDH1A1MEN1KMT2AKDM4E
Dimethylamine SCHEMBL8511811 0.84 KCNN4 (0.43) KCNN4ALDH1A1MAOAMAOBMEN1
SCHEMBL362964 0.84 TSHR (0.43) KCNN4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL15171994 0.78 ESR1 (0.37) KCNN4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL4796677 0.77 MEN1 (0.44) ALDH1A1MEN1KMT2ALMNAHTT
SCHEMBL30056216 0.77 LMNA (0.41) ALDH1A1LMNAL3MBTL1
SCHEMBL16313233 0.76 TSHR (0.45) KCNN4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL1812486 0.76 KIF11 (0.49) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL1793818 0.76 NR1H2 (0.48) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL11571566 0.75 KIF11 (0.47) ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608215-B2 Photochromic ophthalmic or sun protection lenses, glass paneling VISION-EASE LENS, INC. 2003-08-19 US disclosed
US-20030092918-A1 Oxygen-containing heterocyclic fused naphthopyrans VISION-EASE LENS, INC. 2003-05-15 US disclosed
WO-2003025638-A1 OXYGEN-CONTAINING HETEROCYCLIC FUSED NAPHTHOPYRANS VISION-EASE LENS, INC. (US) 2003-03-27 WO disclosed
WO-1999031081-A1 PH SENSITIVE PHOTOCHROMIC DYES JAMES ROBINSON LIMITED (GB) 1999-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092918-A1 Oxygen-containing heterocyclic fused naphthopyrans NQO1, NFE2L2, NDUFV2 KCNN4 2122/4885ALDH1A1 202/4885MAOA 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.